Calidi Biotherapeutics, Inc. (CLDI) quarterly balance sheet — complete assets, liabilities & equity history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 |
|---|
| Total Current Assets | 7.35M | 6.26M | 11.03M | 6.05M | 11.49M | 10.23M | 2.22M | 1.63M | 1.94M | 4.3M | 11.69M | 2.81M | 1.38M | 786K | 460K | 759.67K | 1.03M | 2.74M | 2M |
| Cash & Short-Term Investments | 6.63M | 5.6M | 10.38M | 5.28M | 10.56M | 9.59M | 1.9M | 836K | 1.14M | 2.05M | 10.15M | 1.92M | 919K | 372K | 200K | 328.84K | 597.52K | 2.14M | 1.2M |
| Cash Only | 6.63M | 5.6M | 10.38M | 5.28M | 10.56M | 9.59M | 1.9M | 836K | 1.14M | 2.05M | 10.15M | 1.92M | 919K | 372K | 200K | 328.84K | 597.52K | 2.14M | 1.2M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 0 | 0 | 0 | 50K | 50K | 0 | 0 | 181K | 0 | 1.36M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 238K | 234K | 268K | 343K | 282K | 249K | 216K | 206K | 244K | 125K | 100K | 0 | 0 | 303K | 100K | 0 | 0 | 100K | 0 |
| Total Non-Current Assets | 2.24M | 2.6M | 3M | 3.3M | 3.58M | 3.96M | 4.44M | 4.81M | 5.47M | 5.72M | 6.9M | 7.37M | 6.88M | 1.81M | 1.16M | 230.26M | 230.2M | 651K | 230M |
| Property, Plant & Equipment | 1.34M | 1.68M | 2.01M | 2.33M | 3.43M | 2.93M | 4.22M | 4.58M | 4.96M | 5.34M | 5.46M | 5.73M | 6.01M | 1.09M | 1.01M | 0 | 0 | 585K | 0 |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.69x | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 119K | 119K | 0 | 102K | 123K | 129K | 129K | 356K | 0 | 230K | 0 | 0 | 0 | 0 | 0 | 230.18M | 230.02M | 0 | 230M |
| Other Non-Current Assets | 777K | 800K | 989K | 867K | 21K | 892K | 88K | -129K | 506K | 143K | 1.44M | 1.64M | 868K | 725K | 151K | 77.03K | 178.99K | 66K | -1 |
| Total Assets | 9.59M | 8.86M | 14.03M | 9.35M | 15.06M | 14.18M | 6.66M | 6.43M | 7.41M | 10.02M | 18.59M | 10.18M | 8.26M | 2.6M | 1.62M | 231.02M | 231.24M | 3.39M | 232.01M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.00x | 0.00x | - |
| Asset Growth % | -36.33% | -37.55% | 110.74% | 45.41% | 103.43% | 41.55% | -64.18% | -36.82% | -10.34% | 285.79% | 1048.76% | -95.59% | -96.43% | -23.41% | -99.3% | - | - | - | - |
| Total Current Liabilities | 3.84M | 3.94M | 5.19M | 5.35M | 5.43M | 9.5M | 11.58M | 13.05M | 14.95M | 10.23M | 10.87M | 53M | 49.83M | 42.99M | 35.73M | 373.66K | 386.83K | 25.96M | 47.9K |
| Accounts Payable | 900K | 613K | 1.14M | 1.23M | 1.2M | 2.07M | 3.57M | 4.55M | 3.81M | 2.88M | 1.49M | 677K | 2.54M | 2.12M | 2.26M | 0 | 0 | 624K | 0 |
| Days Payables Outstanding | 159.82 | - | - | - | - | 660.86 | - | - | 812.92 | 552 | 997.28 | 401.88 | 1.15K | - | - | - | - | 1.15K | - |
| Short-Term Debt | 1.5M | 1.52M | 2.28M | 775K | 1.13M | 3.18M | 3.09M | 2.98M | 4.24M | 807K | 3.35M | 9.36M | 8.13M | 5.42M | 4.05M | 0 | 0 | 5M | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.46M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 1.43M | 1.81M | 1.77M | 658K | 762K | 2K | 2M | -188K | 2.38M | 0 | 200K | 35.24M | 32.28M | 29.83M | 24.21M | 373.66K | 386.83K | 16.69M | 47.9K |
| Current Ratio | 1.92x | 1.59x | 2.12x | 1.13x | 2.12x | 1.08x | 0.19x | 0.12x | 0.13x | 0.42x | 1.07x | 0.05x | 0.03x | 0.02x | 0.01x | 2.03x | 2.67x | 0.11x | 41.86x |
| Quick Ratio | 1.92x | 1.59x | 2.12x | 1.13x | 2.12x | 1.08x | 0.19x | 0.12x | 0.13x | 0.42x | 1.07x | 0.05x | 0.03x | 0.02x | 0.01x | 2.03x | 2.67x | 0.11x | 41.86x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 820K | 1.16M | 1.64M | 1.92M | 2.34M | 2.72M | 4.88M | 5.13M | 7.03M | 8.02M | 8.81M | 3.66M | 3.92M | 10.05M | 217K | 9.71M | 14.07M | 43K | 20.93M |
| Long-Term Debt | 600K | 600K | 837K | 600K | 600K | 600K | 2.37M | 1.93M | 3.38M | 2.06M | 1.95M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 153K | 448K | 0 | 1.22M | 1.65M | 1.99M | 2.33M | 2.64M | 2.95M | 3.25M | 3.4M | 3.66M | 3.92M | 447K | 217K | 0 | 0 | 43K | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 67K | 115K | 801K | 103K | 87K | 128K | 176K | 565K | 697K | 2.71M | 3.46M | 0 | 0 | 9.6M | 0 | 9.71M | 14.07M | 0 | 20.93M |
| Total Liabilities | 4.66M | 5.1M | 6.83M | 7.28M | 7.76M | 12.21M | 16.45M | 18.18M | 21.98M | 18.25M | 19.68M | 56.66M | 53.75M | 53.04M | 35.94M | 10.08M | 14.45M | 26M | 20.98M |
| Total Debt | 2.26M | 2.56M | 3.11M | 4.01M | 4.71M | 7.04M | 9.02M | 8.73M | 11.71M | 7.24M | 9.75M | 14.05M | 13.05M | 5.99M | 4.35M | 0 | 0 | 5.18M | 0 |
| Net Debt | -4.37M | -3.04M | -7.26M | -1.27M | -5.86M | -2.56M | 7.13M | 7.9M | 10.57M | 5.19M | -397K | 12.13M | 12.13M | 5.62M | 4.15M | -328.84K | -597.52K | 3.04M | -1.2M |
| Debt / Equity | 0.46x | 0.68x | 0.43x | 1.93x | 0.64x | 3.58x | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -107.00x | -95.69x | -125.12x | -109.71x | -69.26x | -22.69x | -20.85x | -20.10x | -27.54x | -36.08x | -5.21x | -39.84x | -28.76x | -90.69x | -175.38x | - | - | -45.74x | - |
| Total Equity | 4.93M | 3.76M | 7.2M | 2.08M | 7.3M | 1.97M | -9.8M | -11.75M | -14.57M | -8.23M | -1.09M | -46.48M | -45.49M | -50.44M | -34.33M | 220.94M | 216.78M | -22.61M | 211.02M |
| Equity Growth % | -32.39% | 91.01% | 173.46% | 117.67% | 150.09% | 123.9% | -795.61% | 74.71% | 67.97% | 83.67% | 96.81% | -121.04% | -120.99% | -123.08% | -116.27% | - | - | - | - |
| Book Value per Share | 0.48 | 0.52 | 1.47 | 0.72 | 3.25 | 2.96 | -15.09 | -26.57 | -49.39 | -27.93 | -9.21 | -566.87 | -554.88 | -615.22 | -156.10 | 925.89 | 908.46 | -94.76 | 884.34 |
| Total Shareholders' Equity | 4.93M | 3.76M | 6.92M | 1.76M | 6.94M | 1.53M | -10.28M | -11.75M | -14.57M | -8.23M | -1.09M | -46.48M | -45.49M | -50.44M | -34.33M | 220.94M | 216.78M | -22.61M | 211.02M |
| Common Stock | 1K | 1K | 1K | 0 | 3K | 2K | 1K | 1K | 4K | 4K | 4K | 2K | 2K | 2K | 2K | 230.18M | 230.02M | 2K | 230M |
| Retained Earnings | -145.73M | -141.62M | -137.56M | -132.42M | -126.7M | -121.72M | -117.62M | -112.56M | -106.8M | -99.57M | -91.34M | -89.32M | -76.82M | -70.36M | -62.6M | -9.24M | -13.24M | -44.93M | -18.98M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -22K | -13K | -13K | -13K | -26K | -28K | -74K | -27K | 11K | -47K | -4K | -17K | -12K | -14K | -31K | 0 | 0 | -1K | 0 |
| Minority Interest | 0 | 0 | 280K | 312K | 358K | 434K | 485K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |